Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02107794 · ClinicalTrials.gov registry record · NA
Shared Decision Making in Graves Disease - Graves Disease (GD) Choice
A NA study of Graves Disease and Hyperthyroidism, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 93
- Enrollment target
- 1
- Study location
NCT02107794 is a NA study of Graves Disease and Hyperthyroidism that has completed, run by Mayo Clinic. The registered enrollment target is 93 participants, below the 301-participant average among 11 other Graves Disease trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02107794, a NA study of Graves Disease and Hyperthyroidism, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 93 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators' decision aid for patients with GD, GD Choice, will be the result of a user-centered participatory action research involving) synthesis of the best available evidence from the literature and real-world registry experience, ii) input and involvement of patients, clinicians and other stakeholders, iii) direct observation of encounters and iv) extensive field-testing. The goal is to create a decision aid that will be rigorously evidence-based, clear and complete, able to be used by clinicians with minimal training time, while satisfying extant standards for rigorous high-quality shared decision making tools.
Conditions Studied
Interventions
- OTHER Decision Aid
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2012-12 |
| Est. Completion | 2015-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02107794
The ClinicalTrials.gov registry entry for NCT02107794 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 301-participant average among 11 other Graves Disease trials with a reported enrollment target (69% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Graves Disease appearing as the primary indexed condition, and to 1 intervention - of which Decision Aid is the first listed.
NCT02107794 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT02107794 about?
NCT02107794 is a clinical study titled "Shared Decision Making in Graves Disease - Graves Disease (GD) Choice". The investigators' decision aid for patients with GD, GD Choice, will be the result of a user-centered participatory action research involving) synthesis of the best available evidence from the literature and real-world registry experience, ii) input and involvement of patients, clinicians and other...
What is the current status of trial NCT02107794?
This trial is currently completed. It is a NA study. The enrollment target is 93 participants. The study started on 2012-12. Estimated completion is 2015-04.
What conditions does trial NCT02107794 study?
This clinical trial studies the following conditions: Graves Disease, Hyperthyroidism, Thyroid Disease.
What interventions are being tested in trial NCT02107794?
The interventions under investigation include: Decision Aid (OTHER).
Who is sponsoring clinical trial NCT02107794?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02107794 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Graves Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Personalized Treatment in Thyroid Disorders
RECRUITING · NA
-
NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease
RECRUITING · Phase 1
-
Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease
RECRUITING · Phase 2
-
Study of BHV-1300 in Graves' Disease
RECRUITING · Phase 1
-
Preoperative Corticosteroids in Autoimmune Thyroid Disease
RECRUITING · Phase 4
-
The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.